Table 5:

Estimated expected value (median) and [range] of global iVDPV-related introductions by type for 100 stochastic iterations for the time horizon of 2022–2035 for the scenarios modeled with No PAVDs assuming difference vaccines used for outbreak response.

	Expected value of iVDPV-related introductions (median) [range]
Scenario	iVDPV1	iVDPV2	iVDPV3	Total
No PAVD base case	22 (21) [9 – 46]	21 (21) [2 – 53]	10 (10) [1 – 22]	53 (53) [28 – 81]
No PAVD best nOPV	13 (12) [3 – 27]	1 (0) [0 – 9]	10 (9) [1 – 22]	24 (24) [10 – 45]
No PAVD worst nOPV	20 (19) [8 – 40]	25 (26) [2 – 49]	11 (10) [1 – 35]	55 (56) [29 – 81]